News

Organigram Advances Cannabis Product Portfolio with $1M Investment in Phylos

LOS ANGELES- Organigram Holdings Inc. has announced the completion of a partial third tranche investment of $1 million into Phylos Bioscience Inc., a U.S.-based cannabis genetics company. This investment is part of a broader strategy to diversify and enhance Organigram's product offerings, particularly in the auto-flower and rare cannabinoid sectors, including high-potency THCV, CBG, CBC, ...

July 29th, 2024|Capital|

DeSantis Criticizes Cannabis Legalization Initiative’s Ballot Inclusion

LOS ANGELES- Florida Governor Ron DeSantis expressed concerns over the state's cannabis legalization initiative, known as Amendment 3, during a Florida Sheriffs' Association conference. DeSantis argued that the ballot summary for the amendment does not fully represent its content and that the Florida Supreme Court should have prevented it from appearing on the ballot. The ...

July 29th, 2024|Justice|

Week In Review: Dallas Officials Approve Cannabis Decriminalization Petition for November Ballot; Field Trip Health Ltd. Shares Rise 5.8% Amid Increased Trading Volume; SNDL Announces Major Restructuring to Save $20 Million Annually; Verano buys Cannabists Businesses

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it! Cannabis Industry Highlights #1 Dallas Officials Approve Cannabis Decriminalization Petition for November Ballot: Dallas officials have finalized ...

July 29th, 2024|Business, The Week in Review|

SNDL Announces Major Restructuring, Job Cuts to Save $20 Million Annually

LOS ANGELES- Canadian cannabis company SNDL Inc. has announced a significant financial restructuring plan, which includes the elimination of 106 full-time positions. The restructuring aims to optimize corporate overhead spending and consolidate its cannabis segments under the leadership of Tyler Robson. SNDL expects this move to result in annual savings of $20 million, with a ...

July 26th, 2024|Business|

Minnesota Opens Social Equity License Application for Adult-Use Cannabis Market

LOS ANGELES- The Minnesota Office of Cannabis Management (OCM) has initiated the first social equity business license application process for the state's adult-use cannabis market. The application window, which began on Wednesday, will remain open until 11:59 p.m. CT on August 12. This initiative aims to provide early access to the market for social equity ...

July 26th, 2024|Justice|

Tilray Brands’ Aphria RX GmbH Receives License Under Germany’s New Cannabis Law

LOS ANGELES- Tilray Brands, Inc. announced that its German subsidiary, Aphria RX GmbH, has received a cultivation license under Germany's newly enacted adult-use cannabis legalization law. The facility, previously licensed in 2019 for Germany's medical cannabis program, can now cultivate a broader range of cannabis products, expanding from three strains to 31 under the new ...

July 26th, 2024|Justice|

Dallas Officials Approve Cannabis Decriminalization Petition for November Ballot

LOS ANGELES- Dallas officials have finalized a petition allowing voters to decide on a cannabis decriminalization ordinance this November. The proposed measure aims to make the enforcement of Class A and Class B misdemeanor cannabis possession the city's "lowest enforcement priority." If approved, the ordinance would direct city resources away from misdemeanor cannabis enforcement to ...

July 25th, 2024|Justice|

Ohio Accelerates Adult-Use Cannabis Program Implementation

LOS ANGELES- The rulemaking process for Ohio's pending adult-use cannabis program is progressing rapidly, with sales expected to start by the third quarter of this year. Following voter approval of Issue 2, which legalized cannabis possession, use, and home growth for residents aged 21 and older, the Ohio Department of Commerce's Division of Cannabis Control ...

July 25th, 2024|Justice|

Delaware Legalizes Cannabis: Recreational Sales Expected by Late 2024 or Early 2025

LOS ANGELES- Delaware recently legalized adult-use cannabis, but it may be up to two years before consumers can purchase it legally. According to Zoë Patchell, executive director of the Delaware Cannabis Advocacy Network, the state's first legal cannabis sales could begin between late November 2024 and early 2025. The process begins with Delaware Governor John ...

July 24th, 2024|Capital|

Study Highlights Psilocybin’s Significant Impact on Brain Function and Potential Therapeutic Uses

LOS ANGELES- A recent small randomized controlled trial has revealed that a single high dose of psilocybin induces significant and persistent changes in brain functional networks in healthy adults. The findings, published in Nature, provide new insights into the effects of psychedelics on brain activity and their therapeutic potential. The study found that psilocybin's impact ...

July 23rd, 2024|Psychedelics|

Medical Cannabis: Growth and Investment in 2024

LOS ANGELES- The medical cannabis industry is navigating 2024 with key players like Grow Group and Somai Pharmaceuticals leveraging new regulations and market dynamics to achieve ambitious growth targets. This article examines the recent developments and strategic moves shaping the industry’s direction in 2024. England-based medical cannabis operator Grow Group has made significant strides since ...

July 23rd, 2024|Capital|

FDA and FTC Target Delta-8 THC Edibles Resembling Popular Snacks

LOS ANGELES- The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) are taking action against companies selling delta-8 THC edibles packaged to resemble popular snacks, often marketed towards children. Delta-8 THC is a psychoactive substance found in the Cannabis sativa plant, which includes both cannabis and hemp varieties. The FDA and FTC ...

July 22nd, 2024|Justice|

Week In Review: GOP-Led House Committee Approves Spending Bill Blocking Cannabis Rescheduling; Canopy Growth Corporation Stock Performance and Upcoming Earnings Report

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it! Cannabis Industry Highlights #1 GOP-Led House Committee Approves Spending Bill Blocking Cannabis Rescheduling:A key Republican-led House committee ...

July 22nd, 2024|Business, The Week in Review|

Numinus Wellness: Financial Challenges and Strategic Growth in Mental Health Care

LOS ANGELES- Numinus Wellness is at the forefront of transforming mental health care, focusing on innovative treatments, strategic mergers, and operational refinements. This article delves into the market trends, financial performance, and strategic initiatives shaping the future of Numinus Wellness and the broader mental health landscape. Financial Performance: A Mixed Bag of Results Numinus Wellness ...

July 22nd, 2024|Psychedelics|

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands (NYSE: STZ), maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal year 2025 earnings estimate, and supports a higher multiple due to expected sales and earnings growth. Constellation Brands, known for ...

July 19th, 2024|Business|

GOP-Led House Committee Approves Spending Bill Blocking Cannabis Rescheduling

LOS ANGELES- A key Republican-led House committee has approved a large-scale spending bill that would block the Justice Department from rescheduling cannabis. Additionally, the bill amends a longstanding rider protecting medical cannabis states from federal interference by introducing enhanced penalties for sales near schools and parks. This decision comes as part of a broader legislative ...

July 18th, 2024|Justice|

Critics Slam Thai Government’s Approach to Cannabis

LOS ANGELES- Critics have strongly opposed the Thai government's plan to reclassify cannabis as a narcotic, arguing that it will harm businesses involved in cannabis-based products and undermine investor confidence in the country. On July 5, a health committee responsible for controlling illegal drugs voted by majority to reclassify cannabis and hemp as narcotics, effective ...

July 18th, 2024|World|

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands,  maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal year 2025 earnings estimate, and supports a higher multiple due to expected sales and earnings growth. Constellation Brands, known for its Corona ...

July 17th, 2024|Capital|

NHS Reimburses Cannabis for Chemotherapy-Induced Nausea and Vomiting

NEW YORK- The National Health Service (NHS) England has reimbursed a patient for the cost of medicinal cannabis flowers to manage chemotherapy-induced nausea and vomiting (CINV). Michael Roberts, diagnosed with rectosigmoid adenocarcinoma and lung metastases, became the first British patient to receive such a reimbursement.Original Article Michael Roberts (MR) received FOLFIRI chemotherapy and later, FOLFOX ...

July 17th, 2024|Insights|

Aurora Cannabis Submits Regular SEC Filing and Reports

LOS ANGELES- Aurora Cannabis Inc. a  the medicinal chemicals and botanical products industry, has filed a Form 6-K report with the U.S. Securities and Exchange Commission (SEC) for July. The Edmonton, Alberta-based company submitted this routine filing as a foreign private issuer, including a news release dated July 9, 2024, as an exhibit. The filing, ...

July 16th, 2024|Capital|

Medical Cannabis Industry Demonstrates Strong Economic Contributions and Market Trends

LOS ANGELES- The medical cannabis landscape continues to evolve, demonstrating significant economic contributions and offering vital insights into market trends. In 2024, data from licensed dispensaries and cultivation centers highlight robust retail and wholesale activities, reflecting growth and stability in this sector. This article delves into key figures from the past year and historical data ...

July 15th, 2024|Insights|
Go to Top